Biotechnology

Filter

Current filters:

None

Popular Filters

74 to 98 of 2522 results

Anthera reports positive interim analysis of Phase III blisibimod trial

11-02-2015

US development stage biopharma company Anthera Pharmaceuticals saw its share rocket 25% on Wednesday…

Anthera PharmaceuticalsAnti-Arthritics/RheumaticsBiotechnologyblisibimodResearch

No new bidders emerge for Dendreon, so Valeant gets Provenge

No new bidders emerge for Dendreon, so Valeant gets Provenge

11-02-2015

US biotech firm Dendreon revealed yesterday that the bid deadline provided by the Court-approved bidding…

BiotechnologyDendreonMergers & AcquisitionsOncologyProvengeValeant Pharmaceuticals International

Seattle Genetics posts losses but beats analyst forecasts

Seattle Genetics posts losses but beats analyst forecasts

11-02-2015

Bothell, Washington, USA-headquartered oncology specialist Seattle Genetics managed to beat analyst estimates…

AdcetrisBiotechnologyFinancialOncologySeattle GeneticsUSA

Pfenex soars on Lucentis biosimilar deal with Hospira

Pfenex soars on Lucentis biosimilar deal with Hospira

10-02-2015

Shares of US clinical-stage biotech firm Pfenex leapt 28% to $8.85 in morning trading, after the company…

BiosimilarsBiotechnologyGenentechGlobalHospiraLicensingLucentisNovartisOphthalmicsPF582PfenexResearchRoche

Regeneron sees strong Eylea sales; financials beat expectations

Regeneron sees strong Eylea sales; financials beat expectations

10-02-2015

US biotech firm Regeneron Pharmaceuticals today announced financial results for the fourth quarter and…

BayerBiotechnologyEyleaFinancialOphthalmicsRegeneron PharmaceuticalsSanofi

Vaxxas secures equity funding of $20 million to further needle-free vaccine delivery system

Vaxxas secures equity funding of $20 million to further needle-free vaccine delivery system

10-02-2015

Biotech startup Vaxxas has secured equity funding of $20 million from new and existing investors to advance…

AustraliaBiotechnologyFinancialVaccinesVaxxas

BIO releases first-of-its-kind study on venture funding for therapeutic innovation

BIO releases first-of-its-kind study on venture funding for therapeutic innovation

10-02-2015

US trade group the Biotechnology Industry Organization (BIO) has released a first-of-its-kind study on…

BiotechnologyBiotechnology Industry OrganizationFinancialResearchUSA

Could there be a Gleevec for brain cancer?

Could there be a Gleevec for brain cancer?

10-02-2015

The drug Gleevec (imatinib mesylate) is well known not only for its effectiveness against chronic myeloid…

BiotechnologyGleevecNeurologicalNovartisResearch

Celgene's Abraxane recommended by Scottish Medicines Consortium

Celgene's Abraxane recommended by Scottish Medicines Consortium

10-02-2015

The Scottish Medicines Consortium has decided to recommend Abraxane (paclitaxel) in combination with…

AbraxaneBiotechnologyCelgene CorpOncologyRegulationUK

Gilead to increase investment in UK

09-02-2015

London's status as a leading center for the life sciences, financial and digital industries has attracted…

BiotechnologyFinancialGilead SciencesUK

Cell Therapy raises record-breaking crowdfunding for stem cell drug

09-02-2015

UK biotech company Cell Therapy has raised over £691,000 ($1 million) through crowdfunding on Crowdcube…

BiotechnologyCardio-vascularCell therapyCell Therapy LtdFinancialHeartcelUK

FDA approves added indication for Genentech’s Lucentis

FDA approves added indication for Genentech’s Lucentis

08-02-2015

The US Food and Drug Administration on Friday approved Swiss pharma giant Roche subsidiary Genentech’s…

BiotechnologyGenentechLucentisNovartisOphthalmicsRegulationRocheUSA

Alexion’s Soliris price to be reviewed by Canadian regulator

07-02-2015

Canada’s Patented Medicine Prices review Board (PMPRB) will hold a public hearing in the matter of…

Alexion PharmaceuticalsBiotechnologyCanadaPricingRare diseasesSoliris

European Commission approves added indication for Janssen’s Velcade, in MCL

European Commission approves added indication for Janssen’s Velcade, in MCL

06-02-2015

US health care giant Johnson & Johnson (NYSE: JNJ) subsidiary Janssen-Cilag International NV (Janssen)…

BiotechnologyEuropeJanssen-Cilag InternationalJohnson & JohnsonOncologyRegulationVelcade

Nano-carrier drugs for pancreatic cancer now being produced In China

06-02-2015

At the Symposium on the Application of Genetic Testing in Individualized Diagnosis and Treatment of Tumor…

BiotechnologyChinaOncologyResearch

Genticel licenses Vaxiclase platform to Serum Institute of India

04-02-2015

French biotech firm Genticel, a developer of therapeutic vaccines, has licensed its Vaxiclase technology…

BiotechnologyGenticelSerum Institute of IndiaVaxiclase

Gilead beats 4th-qtr 2014 expectations, as hepatitis C drug sales soar

Gilead beats 4th-qtr 2014 expectations, as hepatitis C drug sales soar

04-02-2015

US biotech firm Gilead Sciences posted fourth-quarter and full-year financial results after markets closed…

Anti-viralsBiotechnologyFinancialGilead SciencesHarvoniSovaldi

Pfizer abandons deal with Repligen on SMA drug candidate

Pfizer abandons deal with Repligen on SMA drug candidate

03-02-2015

US biologics specialist Repligen revealed in a filing with the Securities and Exchange Commission that…

BiotechnologyLicensingNeurologicalPfizerRepligenRG3039

New biotech start-up OptiKira created by BioMotiv

New biotech start-up OptiKira created by BioMotiv

02-02-2015

USA-based BioMotiv, a drug development accelerator associated with The Harrington Project, the University…

BioMotivBiotechnologyDiabetesMergers & AcquisitionsOptiKiraRare diseasesResearch

Chimerix to drop development of brincidofovir for Ebola

Chimerix to drop development of brincidofovir for Ebola

02-02-2015

US antiviral biopharma company Chimerix says that, after discussion with the US Food and Drug Administration,…

Anti-viralsBiotechnologybrincidofovirChimerixResearchTropical diseasesUSA

NicOx in-licenses AzaSite and BromSite from InSite Vision

NicOx in-licenses AzaSite and BromSite from InSite Vision

02-02-2015

Ophthalmology-focused French biotech firm NicOx has signed a license agreement with USA-based InSite…

AzaSiteBiotechnologyBromSiteEuropeInSite VisionLicensingNicOxOphthalmicsRest of the World

Motif Bio to list on AIM to progress novel antibiotic

Motif Bio to list on AIM to progress novel antibiotic

02-02-2015

Motif Bio has announced its intention to list on the alternative Investment Market to raise at least…

Antibiotics and Infectious diseasesBiotechnologyFinancialMotif BiosciencesUK

Biogen Idec 2014 revenues and earnings rocket

30-01-2015

US biotech major Biogen Idec yesterday reported full-year and fourth quarter 2014 results, showing that…

Biogen IdecBiotechnologyFinancial

74 to 98 of 2522 results

Back to top